中文 | English
Return
Total: 21 , 1/3
Show Home Prev Next End page: GO
Author:( Yingcheng LIN)

1.Anti-tumor clinical research of mTOR inhibitor

Xuyuan LI ; Yingcheng LIN

Journal of International Oncology 2012;39(5):363-366

2.Treatment strategies of unresectable metastatic colorectal cancer

Haoquan CAI ; Yingcheng LIN

Journal of International Oncology 2012;39(10):775-778

3.Medical therapy of advanced biliary tract cancer

Xuyuan LI ; Yingcheng LIN

Journal of International Oncology 2011;38(12):933-936

4.Roles of bisphosphonate in the adjuvant treatment of breast cancer

Xuyuan LI ; Yingcheng LIN

Journal of International Oncology 2012;(12):925-928

5.Intellectualization construction of hospital outpatient service building

Yingcheng GU ; Xiurong LIN

Chinese Medical Equipment Journal 2004;0(08):-

6.Research progress of kinetochore protein CENP-F in malignant tumor

Jin ZHENG ; Yingcheng LIN

Journal of International Oncology 2014;(7):500-502

7.Molecular predictive biomarkers in non-small-cell lung cancer

Qiuming WANG ; Wanlan HUANG ; Yingcheng LIN

Journal of International Oncology 2011;38(4):278-281

8.Advances in the antitumor research of PARP inhibitor

Xuyuan LI ; Weibing LI ; Yingcheng LIN

Journal of International Oncology 2011;38(3):185-188

9.Current research status of TOP2A gene with response to anthracycline-based chemotherapeutic agents in breast cancer

Xuyuan LI ; Weibing LI ; Yingcheng LIN

Journal of International Oncology 2011;38(2):127-129

10.Relationship between hepatitis B virus infection and B-cell non-Hodgkin lymphoma

Wen LIN ; Yingcheng LIN ; Hongbiao WANG ; Wenzhao LIN ; Suiling LIN ; Weibing LI

Cancer Research and Clinic 2012;24(1):28-30

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 21 , 1/3 Show Home Prev Next End page: GO